General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Dividend information

Continuously rising dividend since 1996

The Board of Directors proposed a 2% increase in the dividend payment for 2012 to CHF 2.30 per share (2011: CHF 2.25), and this was approved at the Annual General Meeting on February 22, 2013.

This represented the 16th consecutive increase in the dividend paid per share since the creation of Novartis in December 1996.

Payment of the dividend was made from March 1, 2013 to those shareholders holding Novartis shares on February 25, 2013.
From February 26, 2013 the shares have been trading ex-dividend.

Stock chart